FOXP1 and nasopharyngeal carcinoma: Downregulates FOXP1 and its tumor‐suppressive effect, inhibits FOXP1‐induced differentiation of TAM, promotes proliferation and inflammation‐induced carcinogenesis of gastric cancer and nasopharyngeal carcinoma.